Meeting Report: Targeting Protein Phosphatases-Medicines for the New Millenium
Shirish Shenolikar1* and
David L. Brautigan2
1Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, NC 27710, USA.
2Departments of Microbiology and Medicine, Center for Cell Signaling, University of Virginia School of Medicine, Charlottesville, VA 22908, USA.
A review of the meeting Protein Phosphatases, FASEB Summer Research Conference, Copper Mountain, CO, 23 to 28 July 2000.
Summary:
Shenolikar and Brautigan summarize the key issues discussed at the conference on protein phosphatases of the Federation of American Societies for Experimental Biology (FASEB). A theme of the meeting was how basic research in the field of protein phosphatases has led to better understanding and treatments for human disease, including type 2 diabetes and obesity. A second important issue presented related to identification and characterization of various phosphatase-binding proteins that regulate phosphatase action.
Corresponding author. E-mail: sheno001@mc.duke.edu
